Van Brabandt H - Search Results

1

TAVI: reveal the truth, the whole truth, and nothing but the truth.

Neyt M, Van Brabandt H. Neyt M, et al. Among authors: van brabandt h. J Med Econ. 2013;16(5):581-5. doi: 10.3111/13696998.2013.772724. Epub 2013 Feb 12. J Med Econ. 2013. PMID: 23368739 Free article. No abstract available.

2

Transcatheter aortic valve implantation (TAVI): risky and costly.

Van Brabandt H, Neyt M, Hulstaert F. Van Brabandt H, et al. BMJ. 2012 Jul 31;345:e4710. doi: 10.1136/bmj.e4710. BMJ. 2012. PMID: 22849955 No abstract available.

3

Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context.

Neyt M, Thiry N, Ramaekers D, Van Brabandt H. Neyt M, et al. Among authors: van brabandt h. Appl Health Econ Health Policy. 2008;6(1):67-80. doi: 10.2165/00148365-200806010-00006. Appl Health Econ Health Policy. 2008. PMID: 18774871

4

The importance of the comparator in economic evaluations: working on the efficiency frontier.

Neyt M, Van Brabandt H. Neyt M, et al. Among authors: van brabandt h. Pharmacoeconomics. 2011 Nov;29(11):913-6. doi: 10.2165/11595260-000000000-00000. Pharmacoeconomics. 2011. PMID: 21988290 No abstract available.

5

Cost-effectiveness of transcatheter aortic valve replacement: overoptimistic study results and a call for publication of complete trial results.

Neyt M, Van Brabandt H. Neyt M, et al. Among authors: van brabandt h. Heart. 2012 Jul;98(13):1031-3; author reply 1033-4. doi: 10.1136/heartjnl-2012-301813. Epub 2012 Apr 27. Heart. 2012. PMID: 22543269 No abstract available.

6

What is the evidence in favor of percutaneous aortic valve insertion?

Van Brabandt H, Neyt M. Van Brabandt H, et al. Am J Cardiol. 2009 Feb 15;103(4):575. doi: 10.1016/j.amjcard.2008.12.003. Am J Cardiol. 2009. PMID: 19195527 No abstract available.

7

Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literature.

Neyt M, Van Brabandt H, Devriese S, De Laet C. Neyt M, et al. Among authors: van brabandt h. Health Policy. 2009 Jul;91(2):107-20. doi: 10.1016/j.healthpol.2008.11.014. Epub 2009 Jan 9. Health Policy. 2009. PMID: 19135756 Review.

8

Percutaneous pulmonary and aortic valve insertion in Belgium: going for conditional reimbursement or waiting for further evidence?

Neyt M, Vinck I, Gewillig M, Van Brabandt H. Neyt M, et al. Among authors: van brabandt h. Int J Technol Assess Health Care. 2009 Jul;25(3):281-9. doi: 10.1017/S0266462309990080. Int J Technol Assess Health Care. 2009. PMID: 19619346 Review.

9

Safety of percutaneous aortic valve insertion. A systematic review.

Van Brabandt H, Neyt M. Van Brabandt H, et al. BMC Cardiovasc Disord. 2009 Sep 1;9:45. doi: 10.1186/1471-2261-9-45. BMC Cardiovasc Disord. 2009. PMID: 19723312 Free PMC article. Review.

10

The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations.

Neyt M, Van Brabandt H, Devos C. Neyt M, et al. Among authors: van brabandt h. BMC Cardiovasc Disord. 2013 Sep 26;13:78. doi: 10.1186/1471-2261-13-78. BMC Cardiovasc Disord. 2013. PMID: 24070126 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters